ARTESIAN THERAPEUTICS
Artesian Therapeutics, Inc. is a privately-held biopharmaceutical company discovering and developing a new generation of novel disease modifying therapeutics for the treatment of cardiovascular disease (CVD), by far the leading cause of death in the North America.
ARTESIAN THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2002-01-01
Status:
Active
Similar Organizations
Allovate
Allovate is a biopharmaceutical company creating innovative treatments for people with allergies.
Cube Psytech
Cube Psytech is a Canadian bio-pharmaceutical and biotechnology company.
Elios Therapeutics
Elios Therapeutics is a biopharmaceutical company.
IsoTherapeutics Group
IsoTherapeutics Group LLC is a radiopharmaceutical company.
Lumen Therapeutics
Lumen Therapeutics is a biopharmaceutical company that works with oligo-L-arginine.
Northern Therapeutics
Northern Therapeutics is a biopharmaceutical company
UCI Therapeutics
UCI Therapeutics is a biopharmaceutical company.
Wuhan Hiteck Biological Pharma
Wuhan Hiteck Biological Pharma operates as a biopharmaceutical company.
More informations about "Artesian Therapeutics"
Artesian Therapeutics - Crunchbase Company Profile & Funding
Artesian Therapeutics is a biopharmaceutical company. Artesian Therapeutics, Inc. is a privately-held biopharmaceutical company discovering and developing a new generation of novel disease modifying therapeutics for the treatment of cardiovascular disease (CVD), by far the leading …See details»
Artesian Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Artesian Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, and 2 literature.See details»
Artesian Therapeutics Company Profile 2024: Valuation, Investors ...
The current revenue for Artesian Therapeutics is . How much funding has Artesian Therapeutics raised over time? Artesian Therapeutics has raised $5.46M. Who are Artesian Therapeutics’s …See details»
ARTESIAN THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ARTESIAN THERAPEUTICS, INC. of Gaithersburg, MD. Get the latest business insights from Dun & …See details»
Artesian Therapeutics Inc - Company Profile and News
Company profile page for Artesian Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Artesian Therapeutics Selects Evotec OAI as Drug Discovery Partner
Artesian Therapeutics, Inc. is a privately-held biopharmaceutical company discovering and developing the first generation of novel disease modifying and disease reversing therapeutics …See details»
Artesian Therapeutics - Overview, News & Similar companies
Artesian Therapeutics, Inc. is a privately-held biopharmaceutical company discovering and developing the first generation of novel disease modifyin g and disease reversing therapeutics …See details»
Artesian Therapeutics Inc. - careersinpharmaceutical.com
Artesian Therapeutics Inc., is located at Gaithersburg, MD and is a privately-held biopharmaceutical company discovers and develops the first generation of disease modifying …See details»
Artesian Therapeutics - Tech Company Profile - Gaebler.com …
Artesian Therapeutics, Inc is a privately-held biopharmaceutical company founded in March of 2002, to discover and develop the first generation of disease modifying and disease reversing …See details»
Artesian Therapeutics Company Profile | Management and
Find contact information for Artesian Therapeutics. Learn about their Manufacturing market share, competitors, and Artesian Therapeutics's email format.See details»
First Patient Dosed in Phase 2 Trial of Descartes-08 for Systemic …
Jul 14, 2024 GAITHERSBURG, Md., July 02, 2024 – Artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology firm known for pioneering mRNA cell therapy for …See details»
Artesian Therapeutics - Overview, Competitors, And Employees
Artesian Therapeutics`s Overview, Revenue, Employee Size, Location For Free. Find Key Decision Makers Of Artesian Therapeutics Email, Phone, LinkedIn Profile.See details»
First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic ...
Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential …See details»
AT-107 - Drug Targets, Indications, Patents - Synapse
01 Feb 2005 · Journal of Pharmacology and Experimental Therapeutics Q3 · MEDICINE Pharmacological Effects of ATI22-107 [2-(2-{2-[2-Chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin …See details»
People - Cartesian
Decades of experience Our leadership brings decades of clinical, R&D and management experience. Our founders previously started and sold two life science companies to Abbvie …See details»
Home - Cartesian
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class …See details»
Cartesian Therapeutics Announces Landmark Study in The Lancet …
Jun 21, 2023 Modifying patients’ T-cells with mRNA to express a chimeric antigen receptor (rCAR-T therapy), a novel approach to treat myasthenia gravis and other autoimmune …See details»
Selecta Biosciences Announces Merger with Cartesian Therapeutics
Nov 13, 2023 Management and Organization ... Cartesian Therapeutics is a clinical-stage company pioneering RNA cell therapies for the treatment of autoimmune diseases. The …See details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry
1 day ago Upon completion of the Merger, pre-Merger Cara Therapeutics stockholders are expected to own approximately 17.0% of the combined company and pre-Merger Tvardi …See details»
Cartesian Therapeutics Highlights Progress and 2024 Strategic ...
Jan 8, 2024 Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a …See details»